Mark Oldakowski serves as Executive at Bionano Genomics, Inc, where they oversee executive responsibilities. Since joining the company, Mark Oldakowski has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 11, 2025 involved selling 59 shares valued at $240.
Mark Oldakowski currently holds 915 shares of Bionano Genomics, Inc (BNGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Oldakowski has been a net neutral trader of BNGO stock. They have purchased $0 and sold $0 worth of shares.
Mark Oldakowski's most recent insider trade was on Sep 11, 2025, when they sold 59 shares at $4.06 per share.
Get notified when new Form 4 filings are submitted
| $4.06 |
| Discretionary |
| Sep 11, 2024 | BNGO | $1.7K | Payment | 3,568 | $0.48 | Discretionary |
| Jun 3, 2024 | BNGO | $0 | Award | 16,000 | $N/A | Discretionary |
| Feb 15, 2024 | BNGO | $1.6K | Payment | 1,229 | $1.27 | Discretionary |
| Sep 18, 2023 | BNGO | $0 | Award | 20,000 | $N/A | Discretionary |
| May 12, 2023 | BNGO | $27.4K | Payment | 41,496 | $0.66 | Discretionary |
| Feb 15, 2023 | BNGO | $0 | Award | 120,000 | $N/A | Discretionary |
| May 12, 2022 | BNGO | $58.5K | Payment | 41,496 | $1.41 | Discretionary |
| May 12, 2021 | BNGO | $0 | Award | 240,000 | $N/A | Discretionary |